The partnership with Cerebras involves a multimillion-dollar agreement that will last several years, with Cerebras providing hardware and software development services. The collaboration with Techcyte aims to create an open, end-to-end, AI-driven solution for more accurate treatment, allowing healthcare organizations to digitize their pathology practices. The platform will integrate pathologists, LIS vendors, whole slide scanner manufacturers, storage, AI providers, biopharma, and labs.
Key takeaways:
- Mayo Clinic has announced partnerships with two AI-driven companies, Cerebras and Techcyte, to accelerate personalized medicine capabilities and offerings.
- Cerebras, a Silicon Valley startup, will work with Mayo Clinic to develop AI models that can summarize medical records, identify patterns in medical images, and analyze genome data.
- Mayo Clinic has also expanded its relationship with Techcyte to create a digital pathology platform with open, end-to-end, AI-driven solutions for more accurate treatment.
- The collaboration with Techcyte will also result in a software as a service-based digital pathology platform that integrates various stakeholders in the healthcare industry, including pathologists, LIS vendors, whole slide scanner manufacturers, storage, AI providers, biopharma, and labs.